Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine
Clinical trial NCT00274976 · COMPLETED
Trial details
- NCT number
- NCT00274976
- Sponsor
- German CLL Study Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.